Bimoo

When was the last time you flossed your teeth? 👀

On the 21st of October we're having an AMA session with the researchers who are regrowing tooth enamel. Whether you floss or not, you should probably come 🦷
https://lu.ma/yghogy3e

The drug development game needs a new playbook—one that prioritizes innovation over profit.

It's time we put researchers back in the driver’s seat.

Molecule is handing over the keys—giving researchers control over their research.

Welcome to the future of scientific funding👇

What a month!

September updates:

🪱 @pumpdotscience opened a can of worms at @SolanaConf
🧬 New Catalyst projects
🧪 @bioprotocol's $BIO Genesis 2
♀️ @athena_DAO_'s first IP-NFT results, crowd sale soon
⛓️ @a16z joins DeSci w/ @Amino_Chain
🎪 @ZelarCity Popup

Let's dig in 🧵

We're hiring a Senior Web3 Backend Engineer 👾

You’ll work hand in hand with the contract and onchain team members to come up with innovative and efficient solutions for questions around data aggregation, API building, onchain queries.

Apply here 👇
https://moleculeto.notion.site/Senior-Web3-Backend-Engineer-11b1aff7be4980e8abcaf75d86ad27c5

AI and LLMs are rapidly shifting how we work, and science is no different. 🧬

The conversation around drug discovery is particularly intriguing - and urgent. With drug development costs of $2.6B and a 90% failure rate, pharma needs AI more than ever.

But is AI living up to its promise? 🧵

🌟 You may have superb vision now, but what about in 30, 40, or 50 years?

The latest Catalyst project aims to change retinopathy treatment by managing cellular "traffic" with small molecules. Catalyst uses a bonding curve and should the project reach its funding goal, funders will receive intellectual property tokens.

If you'd like to learn how you can support Dr Gian De Nicola's research, check out his project page below ⤵️ https://catalyst.molecule.xyz/projects/30711768572520094174636240321978221127381554376287419178177739774099697790665

We're hosting a DeSci gathering during ZelarCity 🧬

You can expect interesting talks, sharing of ideas and discussions around the interplay of longevity and DeSci.

🗓️ 26 October
📌 Konig Gallery, Berlin
https://lu.ma/4spe1nm5

Ready to play the ultimate game of life? 👾🎮

Pump.science is coming to @solana!

Real experiments. Real results.

Ready to play the ultimate game of life? 👾🎮

Pump.science is coming to @solana!

Real experiments. Real results.

Ready to play the ultimate game of life? 👾🎮

Pump.Science is coming to @solana!

Real experiments. Real results.

The scientific funding landscape is evolving 🧪

@balajis
breaks down fresh strategies for researchers to secure funding👇

Ever thought about how DeSci could help prevent lobotomies? 🧠

Yup, us neither - until we learned about Project ACCeleration which focuses on brain tissue regeneration.

Sounds like science fiction? It's not! 🧪 A number of other companies have already begun work on brain tissue replacement, however, none are focusing on the anterior cingulate cortex (ACC)—the area of the brain responsible for attention, impulse control, pain, emotion, and decision-making, which makes us distinctly human.

Issues in the ACC are linked to several severe mental health disorders and in the most extreme cases, surgical interventions where lesions are formed on the brain still occur!

The research team has asked a fundamental question: If we can replace other organs in the body, why not brain tissue? And how can we restore it to full function? 🔬

To learn more check out their project page ⤵️
https://catalyst.molecule.xyz/projects/39245133478057767718273076761575227554872694264533187482187910457937409499134

Do you hear that? That's the sound of the science funding engine revving up. 👀💥

Another project is live on Catalyst! The team is raising funds to tackle enamel regeneration (a world first) and is involving the crypto community. 🪥 🦷

Want to learn more? Check out the project page 👉 https://catalyst.molecule.xyz/projects/10499240999811963149921858998146129963617920505705143737749870206821378971762

Are you an engineer eager to be at the forefront of DeSci? ⚙️

Molecule is hiring a Protocol Engineer to help build the future of onchain science!

Interested? Apply now ➡️ https://moleculeto.notion.site/Protocol-Engineer-53f7a148d4df408587f23e7ad509e164

𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐢𝐬 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠.

𝙏𝙬𝙤 𝙣𝙚𝙬 𝙥𝙧𝙤𝙟𝙚𝙘𝙩𝙨 𝙖𝙧𝙚 𝙡𝙞𝙫𝙚 𝙤𝙣 𝘾𝙖𝙩𝙖𝙡𝙮𝙨𝙩, 𝙧𝙚𝙖𝙙𝙮 𝙛𝙤𝙧 𝙛𝙪𝙣𝙙𝙞𝙣𝙜.

Here is a sneak peek 👇

🔬𝗔𝗯𝟰𝗔𝗗: 𝗮𝗶𝗺𝘀 𝘁𝗼 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗽𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 to develop a low-cost, non-invasive diagnostic tool for early detection of Alzheimer's in asymptomatic individuals

🧠 𝗔𝗖𝗖: 𝘀𝗲𝗲𝗸𝗶𝗻𝗴 𝘁𝗼 𝗿𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗲 𝘁𝗵𝗲 𝗔𝗖𝗖, a key brain region for decision-making and emotions, by engineering lab-grown tissue to replace damaged areas.

🌐 𝘽𝙚 𝙥𝙖𝙧𝙩 𝙤𝙛 𝙩𝙝𝙚 𝙛𝙪𝙩𝙪𝙧𝙚 𝙤𝙛 𝙧𝙚𝙨𝙚𝙖𝙧𝙘𝙝.
Check out the projects on Catalyst.
http://catalyst.molecule.xyz

It's time to bring DeSci to the masses. We are excited to announce a DeSci Guild with @Superteam!

Join us on X Spaces, September 5th, for the first session, "WTF is DeSci?" Hear from key projects and leaders about the problems #DeSci solves.

🔔 Follow the link below and set your reminder 🔔
https://x.com/i/spaces/1YqKDkrzMMkxV

Molecule is hiring! 🚨

Join our team of passionate individuals dedicated to transforming the future of scientific funding! We're hiring an Assistant to the CEO / Founder's Associate in Berlin/EU.

Apply today 👉 https://www.linkedin.com/jobs/view/4009384681/

Project Transfidelity has reached its funding goal on Catalyst! 🍾🎉

Let this moment be a signal to all - the crypto community stands at the precipice of something great. It's time to use our power for good.

Join the telegram chat here: https://t.me/+oCpuM5fWeJMyY2Yx

The 76 ETH raised will support Dr Dimitri Scherbakov and Dr Rashid Akbergenov's work on a potential Alzheimer's treatment.

With over 50 years of combined experience, we are excited to see them get to work. Keep your eyes peeled for research updates 👀

We are hosting a Researcher AMA with Project Transfidelity's scientists on Thursday 👨‍🔬

This is why we love what we do - where else can you directly interact with and support researchers who are solving problems for you?

You can set a reminder here ⤵️

Why has the UK has just decided that they will not cover the cost of lecanemab, one of the few Alzheimer's medications on the market?

➡️ The drug only moderately slows down the disease
➡️ There are risks of serious, even deadly, side-effects
➡️ Treatment costs over $20k a year

It's clear that better solutions are needed. Researchers like Dr Dimitri Scherbakov & Dr Rashid Akbergenov are trying to do just that. There are 4 days left to support their work via Catalyst, the #DeSci funding machine.

Follow the link in our bio to learn more! 🖇️

👾 Calling all devs!

We're looking for a Full Stack Solana Engineer to join our team & bring DeSci to the Solana ecosystem 👀

If you have experience managing automated trading & assisting with frontend integrations, we want to hear from you.

Apply Now: